We specialize in the health sector and the pharmaceutical industry. Over many years, we have gained the trust of many clients, carrying out dozens of projects and many trainings for them. We operate mainly on behalf of the pharmaceutical industry, we have carried out many unusual projects and conducted unique trainings. Many drug manufacturers and other healthcare institutions have trusted us. We focus on an innovative approach to the tasks entrusted to us and continuous development. We offer:
72.19.Z - Other research and experimental development on natural sciences and engineering
18.13.Z - Pre-press and pre-media services
58.19.Z - Other publishing activities
63.99.Z - Other information service activities not elsewhere classified
70.21.Z - Public relations and communication activities
70.22.Z - Business and other management consultancy activities
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
82.30.Z - Organisation of conventions and trade shows
96.09.Z - Other personal service activities not elsewhere classified
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Net sales | 0,3 | 0,4 | 1,2 | 169,2 |
Liabilities and provisions | 0,1 | 0,1 | 0,1 | -1,3 |
Equity | 0,1 | 0 | 0,2 | 805,5 |
Total assets | 0,1 | 0,2 | 0,4 | 131,3 |
Cash and cash equivalents | 0,1 | 0,1 | 0,1 | 55,1 |
Depreciation | 0 | 0 | 0 | 0 |
Gross profit / loss | 0 | -0 | 0,2 | 795,8 |
EBITDA | 0 | -0 | 0,3 | 853,6 |
Net profit / loss | 0 | -0 | 0,2 | 737,9 |
Operating profit (EBIT) | 0 | -0 | 0,3 | 853,6 |
Current assets | 0,1 | 0,2 | 0,4 | 131,3 |
% | % | % | p.p. | |
Return on equity (ROE) | 62,6 | -126,3 | 89 | 215,3 |
Return on sales (ROS) | 15 | -7,8 | 18,5 | 26,3 |
Equity ratio | 43,9 | 16,4 | 64,4 | 48 |
EBITDA margin | 16,3 | -7,6 | 21,2 | 28,8 |
Gross profit margin | 16,3 | -7,8 | 20,2 | 28 |
Days | Days | Days | Days | |
Current liabilities turnover ratio | 112 | 115 | 42 | -73 |
Current ratio | 1,8 | 1,2 | 2,8 | 1,6 |
Net debt to EBITDA | -0,3 | 2,5 | -0,5 | -3 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.